Patients treated surgically for upper tract urothelial carcinoma are not usually offered adjuvant chemotherapy, and for those who are, the treatment does not seem to have much impact on the odds of survival, according to a study published in the September issue of the Journal of Urology.
For much more information read the article at modern medicine.